Guidance for Treating Patients with Opioid Use Disorder (OUD) with Buprenorphine- Naloxone (B/N) in the COVID-19 Era via Telehealth: A Review of Previous Evidence, New COVID-19 OUD Treatment Guidelines, and a Case Report of their Application

Deep Blue Home

Show full item record

Accessibility: If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.

This item appears in the following Collection(s)

Search Deep Blue

Browse by

My Account


Coming Soon

MLibrary logo